Enveric Biosciences annual gross margin
2015
2016
2017
2018
2019
Enveric Biosciences Gross Margin Growth & History (ENVB)
Enveric Biosciences's gross margin was 20.42% for fiscal 2019.
View full Enveric Biosciences company overviewEnveric Biosciences annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2019 | 2019-12-31 | 20.42% | −0.47 pp |
| 2018 | 2018-12-31 | 20.89% | −0.18 pp |
| 2017 | 2017-12-31 | 21.07% | +1.90 pp |
| 2016 | 2016-12-31 | 19.17% | −14.74 pp |
| 2015 | 2015-12-31 | 33.91% | — |
Enveric Biosciences quarterly gross margin
Q2.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q3 2020 | 2020-09-30 | 22.25% | +1.49 pp |
| Q2 2020 | 2020-06-30 | 22.02% | +0.40 pp |
| Q1 2020 | 2020-03-31 | 19.59% | −0.43 pp |
| Q4 2019 | 2019-12-31 | 19.08% | +0.54 pp |
| Q3 2019 | 2019-09-30 | 20.76% | −1.42 pp |
| Q2 2019 | 2019-06-30 | 21.63% | +0.06 pp |
| Q1 2019 | 2019-03-31 | 20.03% | −1.15 pp |
| Q4 2018 | 2018-12-31 | 18.53% | +0.72 pp |
| Q3 2018 | 2018-09-30 | 22.18% | +1.72 pp |
| Q2 2018 | 2018-06-30 | 21.57% | +2.55 pp |
| Q1 2018 | 2018-03-31 | 21.18% | −5.57 pp |
| Q4 2017 | 2017-12-31 | 17.81% | −2.04 pp |
| Q3 2017 | 2017-09-30 | 20.46% | +3.59 pp |
| Q2 2017 | 2017-06-30 | 19.01% | −3.68 pp |
| Q1 2017 | 2017-03-31 | 26.75% | +8.85 pp |
| Q4 2016 | 2016-12-31 | 19.85% | −24.05 pp |
| Q3 2016 | 2016-09-30 | 16.87% | −15.40 pp |
| Q2 2016 | 2016-06-30 | 22.69% | −2.31 pp |
| Q1 2016 | 2016-03-31 | 17.90% | −8.20 pp |
| Q4 2015 | 2015-12-31 | 43.90% | — |
| Q3 2015 | 2015-09-30 | 32.26% | — |
| Q2 2015 | 2015-06-30 | 25.00% | −2.05 pp |
| Q1 2015 | 2015-03-31 | 26.11% | — |
| Q2 2014 | 2014-06-30 | 27.04% | — |
Enveric Biosciences gross margin trends
Between the periods ended 2015-12-31 and 2019-12-31, Enveric Biosciences's gross margin decreased from 33.91% to 20.42%, a change of −13.49 percentage points. The latest reported quarter, Q3 2020, shows 22.25%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Enveric Biosciences source filings ↗